The importance of local chemical structure for chemical metabolism by human uridine 5′-diphosphate-glucuronosyltransferase

Journal of Chemical Information and Modeling

Volumn 46, Issue 6, 2006, Pages 2692-2697

  Sorich, Michael J ^a   McKinnon, Ross A ^a   Miners, John O ^b   Smith, Paul A ^b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYSIS; DETOXIFICATION; DRUG PRODUCTS; ENZYMES; MATHEMATICAL MODELS; MOLECULAR STRUCTURE; STRUCTURE (COMPOSITION);

ENVIRONMENTAL CHEMICALS; GLUCURONOSYLTRANSFERASE; HUMAN URIDINE; NUCLEOPHILIC ATOMS;

METABOLISM;

GLUCURONIDE; GLUCURONOSYLTRANSFERASE; ISOPROTEIN; URIDINE DIPHOSPHATE;

ARTICLE; BAYES THEOREM; BINDING SITE; CHEMICAL MODEL; CHEMISTRY; CLUSTER ANALYSIS; HUMAN; METHODOLOGY;

BAYES THEOREM; BINDING SITES; CHEMISTRY; CHEMISTRY, PHARMACEUTICAL; CLUSTER ANALYSIS; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HUMANS; MODELS, CHEMICAL; PROTEIN ISOFORMS; URIDINE DIPHOSPHATE;

EID: 33845767068     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci600248e     Document Type: Article

References (37)

1. Armstrong, R. N. Enzyme-Catalyzed Detoxication Reactions: Mechanisms and Stereochemistry. Crit. Rev. Biochem. 1987, 22, 39-88.
2. Radominska-Pandya, A.; Czernik, P. J.; Little, J. M.; Battaglia, E.; Mackenzie, P. I. Structural and Functional Studies of UDP- Glucuronosyltransferases. Drug Metab. Rev. 1999, 31, 817-99.
3. Miners, J. O.; Smith, P. A.; Sorich, M. J.; McKinnon, R. A.; Mackenzie, P. I. Predicting Human Drug Glucuronidation Parameters: Application of in Vitro and in Silico Modeling Approaches. Anna. Rev. Pharmacol. Toxicol. 2004, 44, 1-25.
4. Miners, J. O.; Mackenzie, P. I. Drug Glucuronidation in Humans. Pharmacol. Ther. 1991, 51, 347-69.
5. Aumont, V.; Krisa, S.; Battaglia, E.; Netter, P.; Richard, T.; Merillon, J. M.; Magdalou, J.; Sabolovic, N. Regioselective and Stereospecific Glucuronidation of trans- and cis-Resveratrol in Human. Arch. Biochem. Biophys. 2001, 393, 281-289.
6. Barbier, O.; Albert, C.; Martineau, I.; Vallee, M.; High, K.; Labrie, F.; Hum, D. W.; Labrie, C.; Belanger, A. Glucuronidation of the Nonsteroidal Antiestrogen EM-652 (SCH 57068), by Human and Monkey Steroid Conjugating UDP-Glucuronosyltransferase Enzymes. Mol. Pharmacol. 2001, 59, 636-645.
7. Burchell, B.; Brierley, C. H.; Rance, D. Specificity of Human UDP-Glucuronosyltransferases and Xenobiotic Glucuronidation. Life Sci. 1995, 57, 1819-31.
8. Doerge, D. R.; Chang, H. C.; Churchwell, M. I.; Holder, C. L. Analysis of Soy Isoflavone Conjugation in Vitro and in Human Blood Using Liquid Chromatography-Mass Spectrometry. Drug Metab. Dispos. 2000, 28, 298-307.
9. Jude, A. R.; Little, J. M.; Bull, A. W.; Podgorski, I.; RadominskaPandya, A. 13-Hydroxy- and 13-Oxooctadecadienoic Acids: Novel Substrates for Human UDP-Glucuronosyltransferases. Drug Metab. Dispos. 2001, 29, 652-5.
10. Kemp, D. C.; Fan, P. W.; Stevens, J. C. Characterization of Raloxifene Glucuronidation in Vitro: Contribution of Intestinal Metabolism to Presystemic Clearance. Drug Metab. Dispos. 2002, 30, 694-700.
11. Stone, A. N.; Mackenzie, P. I.; Galetin, A.; Houston, J. B.; Miners, J. O. Isoform Selectivity and Kinetics of Morphine 3- and 6Glucuronidation by Human UDP-Glucuronosyltransferases: Evidence for Atypical Glucuronidation Kinetics by UGT2B7. Drug Metab. Dispos. 2003, 31, 1086-9.
12. Uchaipichat, V.; Mackenzie, P. I.; Guo, X. H.; Gardner-Stephen, D.; Galetin, A.; Houston, J. B.; Miners, J. O. Human UDP-Glucuronosyl-transferases: Isoform Selectivity and Kinetics of 4-Methylumbelliferone and 1-Naphthol Glucuronidation, Effects of Organic Solvents, and Inhibition by Diclofenac and Probenecid. Drug Metab. Dispos. 2004, 32, 413-23.
13. Cupid, B. C.; Beddell, C. R.; Lindon, J. C.; Wilson, I. D.; Nicholson, J. K. Quantitative Structure-Metabolism Relationships for Substituted Benzoic Acids in the Rabbit: Prediction of Urinary Excretion of Glycine and Glucuronide Conjugates. Xenobiotica 1996, 157-176.
14. Cupid, B. C.; Holmes, E.; Wilson, I. D.; Lindon, J. C.; Nicholson, J. K. Quantitative Structure-Metabolism Relationships (QSMR) Using Computational Chemistry: Pattern Recognition Analysis and Statistical Prediction of Phase II Conjugation Reactions of Substituted Benzoic Acids in the Rat. Xenobiotica 1999, 29, 27-42.
15. Ethell, B. T.; Ekins, S.; Wang, J. B.; Burchell, B. Quantitative Structure Activity Relationships for the Glucuronidation of Simple Phenols by Expressed Human UGT1A6 and UGT1A9. Drug Metab. Dispos. 2002, 30, 734-738.
16. Said, M.; Ziegler, J. C.; Magdalou, J.; Elass, A.; Vergoten, G. Inhibition of Bilirubin UDP-Glucuronosyltransferase -A Comparative Molecular Field Analysis (COMFA). Quant. Struct.-Act. Relat. 1996, 15, 382-388.
17. Smith, P. A.; Sorich, M. J.; Low, L. S. C.; McKinnon, R. A.; Miners, J. O. Modelling Metabolism by UDP-Glucuronosyltransferases. J. Mol. Graphics Modell. 2004, 22, 507-517.
18. Smith, P. A.; Sorich, M. J.; McKinnon, R. A.; Miners, J. O. Pharmacophore and Quantitative Structure-Activity Relationship Modeling: Complementary Approaches for the Rationalization and Prediction of UDP-Glucuronosyltransferase 1A4 Substrate Selectivity. J. Med. Chem. 2003, 46, 1617-1626.
19. Smith, P. A.; Sorich, M. J.; McKinnon, R. A.; Miners, J. O. In Silico Insights: Chemical and Structural Characteristics Associated with UDP-Glucuronosyltransferase (UGT) Substrate Selectivity. Clin. Exp. Pharmacol. Physiol 2003, 30, 836-840.
20. Sorich, M. J.; McKinnon, R. A.; Miners, J. O.; Winkler, D. A.; Smith, P. A. Rapid Prediction of Chemical Metabolism by Human UDP-Glucuronosyltransferase Isoforms Using Quantum-Chemical Descriptors Derived with the Electronegativity Equalization Method. J. Med. Chem. 2004, 47, 5311-7.
21. Sorich, M. J.; Miners, J. O.; McKinnon, R. A.; Smith, P. A. Multiple Pharmacophores for the Investigation of Human UDP-Glucuronosyltransferase Isoform Substrate Selectivity. Mol. Pharmacol. 2004, 65, 301-308.
22. Sorich, M. J.; Miners, J. O.; McKinnon, R. A.; Winkler, D.; Burden, F. R.; Smith, P. A. Comparison of Linear and Non-linear Classification Algorithms for the Prediction of Drug and Chemical Metabolism by Human UDP- Glucuronosyltransferase Isoforms. J. Chem. Inf. Comput. Sci. 2003, 43, 2019-2024.
23. Sorich, M. J.; Smith, P. A.; McKinnon, R. A.; Miners, J. O. Pharmacophore and Quantitative Structure Activity Relationship Modelling of UDP-Glucuronosyltransferase 1A1 (UGT1A1) Substrates. Pharmacogenetics 2002, 12, 635-645.
24. de Hoon, M. J.; Imoto, S.; Nolan, J.; Miyano, S. Open Source Clustering Software. Bioinformatics 2004, 20, 1453-4.
25. R Development Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2005.
26. Agresti, A. A. Survey of Exact Inference for Contingency Tables. Stat. Sci. 1992, 7, 131-153.
27. Bultinck, P.; Langenaeker, W.; Lahorte, P.; De Proft, F.; Geerlings, P.; Waroquier, M.; Tollenaere, J. P. The Electronegativity Equalization Method I: Parametrization and Validation for Atomic Charge Calculations. J. Phys. Chem. 2002, 706, 7887-7894.
28. Bauer, D. F. Constructing Confidence Sets Using Rank Statistics. J. Am. Stat. Assoc. 1972, 67, 687-690.
29. Hand, D. J.; Yu, K. Idiot's Bayes - Not So Stupid after All? Int. Stat. Rev. 2001, 69, 385-399.
30. Demsar, J.; Zupan, B.; Leban, G. Orange: From Experimental Machine Learning to Interactive Data Mining, White Paper; Faculty of Computer and Information Science, University of Ljubljana: Ljubljana, Slovenia, 2004. www.ailab.si/orange (accessed Mar 2006).
31. Hawkins, D. M.; Basak, S. C.; Mills, D. Assessing Model Fit by Cross-Validation. J. Chem. Inf. Comput. Sci. 2003, 43, 579-86.
32. Beck, J. R.; Schultz, E. K. The Use of ROC Curves in Test Performance Evaluation. Arch. Pathol. Lab. Med. 1986 110, 13-20.
33. Voigt, J. H.; Bienfait, B.; Wang, S. M.; Nicklaus, M. C. Comparison of the NCI Open Database with Seven Large Chemical Structural Databases. J. Chem. Inf. Comput. Sci. 2001, 41, 702-712.
34. Bone, R.; Agard, D. A. Mutational Remodeling of Enzyme Specificity. Methods Enzymol. 1991, 202, 643-71.
35. Geerlings, P.; De Proft, F. Chemical Reactivity as Described by Quantum Chemical Methods. Int. J. Mol. Sci. 2002, 3, 276-309.
36. Li, Y.; Evans, J. N. S. The Fukui Function: A Key Concept Linking Frontier Molecular Orbital Theory and the Hard - Soft - Acid - Base Principle. J. Am. Chem. Soc. 1995, 117, 7756-7759.
37. Langenaeker, W.; Demel, K.; Geerlings, P. Quantum-Chemical Study of the Fukui Function as a Reactivity Index. Part 2: Electrophilic Substitution on Mono-substituted Benzenes. J. Mol Struct. 1991, 234, 329.